(Q34268166)

1 August 2017

1 reference

title

Clinical pharmacokinetics of linezolid, a novel oxazolidinone antibacterial (English)

1 reference

1 August 2017

Clinical Pharmacokinetics of Linezolid, a Novel Oxazolidinone Antibacterial (English)

1 reference

https://api.crossref.org/works/10.2165/00003088-200342130-00004

19 March 2024

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.2165/00003088-200342130-00004

19 March 2024

author name string

Dennis J. Stalker

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14531724

19 March 2024

Gail L. Jungbluth

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14531724

19 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14531724

19 March 2024

publication date

1 January 2003

1 reference

Clinical Pharmacokinetics

1 August 2017

1 reference

1 August 2017

42

1 reference

1 August 2017

13

1 reference

1 August 2017

1129-1140

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-200342130-00004

1 August 2017

0 references

cites work

Single dose pharmacokinetics of linezolid in infants and children.

1 reference

12 December 2020

Linezolid: pharmacokinetic and pharmacodynamic evaluation of coadministration with pseudoephedrine HCl, phenylpropanolamine HCl, and dextromethorpan HBr.

1 reference

12 December 2020

Pharmacokinetics, metabolism, and excretion of linezolid following an oral dose of [(14)C]linezolid to healthy human subjects.

1 reference

12 December 2020

Linezolid, a novel oxazolidinone antibiotic: assessment of monoamine oxidase inhibition using pressor response to oral tyramine

1 reference

12 December 2020

Multi-laboratory assessment of the linezolid spectrum of activity using the Kirby-Bauer disk diffusion method: Report of the Zyvox Antimicrobial Potency Study (ZAPS) in the United States

1 reference

12 December 2020

Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study

1 reference

12 December 2020

Comparative in-vitro activities of moxifloxacin, trovafloxacin, quinupristin/dalfopristin and linezolid against staphylococci

1 reference

12 December 2020

Pharmacokinetics of linezolid in subjects with renal dysfunction

1 reference

12 December 2020

Resistance to linezolid: characterization of mutations in rRNA and comparison of their occurrences in vancomycin-resistant enterococci

1 reference

12 December 2020

Randomized comparison of linezolid (PNU-100766) versus oxacillin-dicloxacillin for treatment of complicated skin and soft tissue infections

1 reference

12 December 2020

Oxidation of the novel oxazolidinone antibiotic linezolid in human liver microsomes.

1 reference

12 December 2020

Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections

1 reference

12 December 2020

In vitro activities of linezolid against important gram-positive bacterial pathogens including vancomycin-resistant enterococci

1 reference

12 December 2020

The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria

1 reference

12 December 2020

In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents

1 reference

12 December 2020

Resistance mutations in 23 S rRNA identify the site of action of the protein synthesis inhibitor linezolid in the ribosomal peptidyl transferase center

1 reference

12 December 2020

The pharmacologic and bacteriologic properties of oxazolidinones, a new class of synthetic antimicrobials.

1 reference

12 December 2020

Intrapulmonary pharmacokinetics of linezolid

1 reference

12 December 2020

Linezolid versus ceftriaxone/cefpodoxime in patients hospitalized for the treatment of Streptococcus pneumoniae pneumonia

1 reference

12 December 2020

Pharmacokinetics and tissue penetration of linezolid following multiple oral doses

1 reference

12 December 2020

Linezolid absolute bioavailability and the effect of food on oral bioavailability

1 reference

12 December 2020

Age and sex effects on the pharmacokinetics of linezolid

1 reference

12 December 2020

Clinical pharmacodynamics of linezolid in seriously ill patients treated in a compassionate use programme

1 reference

12 December 2020

A pharmacokinetic evaluation of concomitant administration of linezolid and aztreonam

1 reference

12 December 2020

Pharmacokinetics and tolerance of single- and multiple-dose oral or intravenous linezolid, an oxazolidinone antibiotic, in healthy volunteers

1 reference

12 December 2020

Drug Metabolism and Disposition

15

29

1136

Slatter

2001

1 reference

https://api.crossref.org/works/10.2165/00003088-200342130-00004

Clinical Infectious Diseases

19 March 2024

17

25

487

Jungbuth

1997

1 reference

https://api.crossref.org/works/10.2165/00003088-200342130-00004

Drug Metabolism and Disposition

19 March 2024

19

28

1014

Wynalda

2000

1 reference

https://api.crossref.org/works/10.2165/00003088-200342130-00004

19 March 2024

Identifiers

1 reference

Dimensions Publication ID

1 August 2017

0 references

1 reference